j
u
r
n
l
p
r
e
p
r
f
data
literatur
report
subject
obes
higher
risk
get
howev
sinc
obes
known
increas
risk
develop
sever
form
respiratori
failur
could
hypothes
subject
obes
could
risk
seriou
ill
infect
retrospect
cohort
studi
singl
french
center
evalu
consecut
patient
admit
intens
care
observ
obes
bmi
sever
obes
bmi
present
case
respect
patient
requir
invas
mechan
ventil
imv
increas
bmi
categori
p
greatest
patient
bmi
kgm
well
known
obes
repres
state
low
grade
chronic
inflamm
contribut
onset
metabol
diseas
dyslipidemia
insulin
resist
type
diabet
mellitu
modifi
innat
adapt
immun
respons
make
immun
system
vulner
infect
less
respons
vaccin
antivir
antimicrobi
drug
recent
find
highlight
substanti
impact
obes
immun
pathogen
defens
includ
disrupt
lymphoid
tissu
integr
alter
leukocyt
develop
phenotyp
activ
coordin
innat
adapt
immun
respons
particular
obes
shown
impair
memori
cell
respons
influenza
viru
infect
result
increas
mortal
viral
titer
lung
worsen
lung
patholog
advers
effect
associ
obesityinduc
failur
maintain
influenzaspecif
memori
cell
essenti
ensur
vaccin
efficaci
lowgrad
inflamm
determin
condit
adipocyt
hypoxia
dysfunct
result
exuber
secret
proinflammatori
cytokin
tumor
necrosi
factor
interleukin
il
recruit
immun
cell
macrophag
tcell
bcell
creat
autoregener
inflamm
loop
inde
increas
circul
level
proinflammatori
cytokin
creactiv
protein
report
j
u
r
n
l
p
r
e
p
r
f
overweight
obes
adult
far
limit
scientif
evid
regard
pathophysiolog
mechan
link
obes
interest
inform
extrapol
studi
conduct
subject
infect
shown
subject
obes
compar
normalweight
individu
evinc
infect
intens
releas
chemokin
innat
immun
involv
chemotaxi
major
chemokin
neutrophil
activ
migrat
tissu
mechan
involv
respons
infect
parallel
one
import
mechan
underli
sever
lung
diseas
repres
cytokin
storm
lead
acut
respiratori
distress
syndrom
even
multipl
organ
failur
repres
phenomenon
immun
hyper
activ
similar
cytokinereleas
syndrom
cr
typic
describ
set
cellengag
immunotherapi
character
increas
level
interferon
ifn
cytokin
caus
consequ
symptom
relat
immun
activ
rang
gener
malais
myalgia
fever
sever
organ
toxic
respiratori
failur
death
support
import
counteract
inflammatori
respons
avoid
progress
use
tocilizumab
subject
sever
respiratori
impair
test
encourag
result
tocilizumab
recombin
human
monoclon
antibodi
bind
human
receptor
inhibit
signal
transduct
current
use
rheumatoid
arthriti
efficaci
also
demonstr
form
lung
immunerel
pneumopathi
wherea
consid
subject
obes
proinflammatori
milieu
expect
could
exacerb
inflamm
expos
higher
level
circul
inflammatori
molecul
compar
lean
human
subject
could
explain
increas
risk
sever
complic
subject
obes
obesityrel
comorbid
could
also
repres
addit
risk
factor
complic
obes
fact
hypertens
cardiovascular
diseas
frequent
journal
preproof
j
u
r
n
l
p
r
e
p
r
f
detect
subject
die
itali
suggest
could
increas
risk
mortal
regard
four
risk
factor
diabet
patient
compar
covid
patient
without
diabet
propos
increas
risk
poor
outcom
suscept
hyperglycemia
corticosteroid
therapi
inadequ
glycem
control
lack
contact
healthcar
profession
inappropri
discontinu
angiotensin
receptor
blocker
arb
angiotensin
convert
enzym
ace
inhibitor
individu
synergist
could
justifi
worst
prognosi
patient
covid
fact
also
question
ace
inhibitor
arb
usual
use
treatment
hypertens
could
increas
risk
infect
sever
sinc
increas
express
ace
whose
receptor
use
viru
enter
host
cell
howev
current
suffici
data
support
hypothesi
therefor
american
heart
associ
aha
heart
failur
societi
america
hfsa
american
colleg
cardiolog
acc
releas
statement
recommend
continu
drug
patient
alreadi
receiv
heart
failur
hypertens
ischem
heart
diseas
addit
subject
obes
often
suffer
chronic
obstruct
bronchopathi
asthma
hypoventil
syndrom
obstruct
sleep
apnea
mechan
anomali
due
excess
thorac
abdomin
fat
mass
could
breed
ground
respiratori
complic
anoth
clinic
condit
frequent
encount
subject
obes
metabol
associ
fatti
liver
diseas
mafld
defin
evid
hepat
steatosi
addit
one
follow
three
criteria
overweight
obes
presenc
evid
metabol
dysregul
mafld
patient
especi
obes
level
independ
predict
increas
liver
inflamm
might
play
additivesynergist
role
promot
greater
sever
regard
studi
conduct
three
chines
hospit
patient
mafld
evalu
comput
tomographi
laboratoryconfirm
j
u
r
n
l
p
r
e
p
r
f
analyz
observ
malfd
patient
obes
sever
diseas
nonobes
one
p
subject
sever
obes
compar
nonsever
diseas
p
presenc
obes
mafld
patient
associ
increas
risk
sever
ill
associ
remain
signific
even
adjust
age
sex
smoke
diabet
hypertens
dyslipidemia
suggest
context
mafld
obes
repres
import
risk
factor
sever
obesitydriven
chronic
inflamm
impair
fibrinolysi
contribut
increas
risk
develop
thrombosi
current
seem
one
mechan
potenti
involv
worsen
lung
damag
death
justifi
use
heparin
prophylact
therapeut
purpos
differ
protocol
use
patient
fact
use
pulmonari
cutan
biopsi
autopsi
sampl
individu
sever
document
patient
becam
critic
ill
suffer
gener
thrombot
microvascular
injuri
anoth
common
find
obes
vitamin
defici
report
increas
risk
system
infect
impair
immun
respons
convers
vitamin
supplement
prevent
respiratori
infect
sever
immunoregulatori
function
includ
decreas
product
proinflammatori
cytokin
innat
immun
system
therefor
reduc
risk
cytokin
storm
lead
pneumonia
interestingli
epidemiolog
data
report
itali
one
countri
highest
preval
hypovitaminosi
europ
high
preval
subject
obes
elderli
women
diabet
therefor
base
previou
consider
could
hypothes
vitamin
defici
could
potenti
take
part
link
obes
increas
suscept
complic
mortal
due
j
u
r
n
l
p
r
e
p
r
f
gut
dysbiosi
anoth
import
factor
potenti
involv
increas
risk
develop
sever
form
obes
wellknown
obes
per
se
associ
blunt
composit
gut
microbiom
turn
paramount
regul
host
immun
system
protect
infect
moreov
gut
microbiom
also
role
attenu
damag
consequ
infect
fact
protocol
treatment
includ
use
probiot
maintain
balanc
intestin
microecolog
therefor
indirectli
strengthen
immun
system
final
subject
obes
also
mechan
issu
relat
excess
weight
make
difficult
earli
diagnosi
pulmonari
ultrasound
thu
lead
diagnosi
advanc
stage
associ
highest
mortal
lack
medic
intens
care
unit
design
accommod
patient
sever
obes
difficulti
intub
insert
cathet
relat
excess
weight
may
lead
slowdown
therapeut
step
worsen
prognosi
patient
obes
furthermor
infect
subject
obes
current
subject
strict
measur
contain
pandem
close
monitor
includ
use
telemedicin
requir
less
physic
activ
unhealthi
food
consumpt
process
longlif
food
calor
food
reduct
healthier
fresh
option
fruit
veget
stress
anxieti
sleep
depriv
pressur
social
distanc
taken
togeth
subject
obes
highrisk
complic
group
patient
treat
increas
requir
hospit
subject
obes
need
intens
attent
reduc
risk
fatal
thu
paramount
subject
avoid
infect
follow
gener
prevent
advic
given
author
order
reduc
spread
viru
fund
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
